查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1547058

PMS、月經保健品市場：全球產業分析、規模、佔有率、成長、趨勢、預測，2024-2031年

PMS & Menstrual Health Supplements Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031
出版日期: | 出版商: Persistence Market Research | 英文 210 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

Persistence Market Research最近發布了一份關於PMS、月經保健品市場的綜合報告。本報告全面評估了主要市場動態，包括驅動因素、趨勢、機會和挑戰，並提供了有關市場結構的詳細見解。

關鍵見解

  • PMS、月經保健品市場規模（2024年）：242億美元
  • 預測市場價值（2031年）：356億美元
  • 全球市場成長率（2024-2031年年複合成長率）：5.6%

PMS、月經保健品市場：調查範圍

PMS、月經保健品目的是緩解與經前症候群（PMS）相關的症狀和經期不適（如腹脹、情緒低落和疼痛）。這些補充劑通常含有維生素、礦物質、草藥萃取物和其他天然成分，目的是改善月經健康和整體健康。該市場迎合不同年齡層和健康狀況的女性，提供各種產品，包括營養補充劑、草藥和功能性食品。市場成長的驅動力是人們對月經健康的認識不斷提高、對天然成分和有機補充劑的需求不斷增加以及對女性健康和保健的日益關注。

推動市場成長的因素：

全球PMS、月經保健品市場由幾個關鍵因素推動，包括人們對PMS、月經健康管理解決方案的認識和接受度不斷提高。經前症候群/月經失調的盛行率不斷上升，加上消費者對天然和有機補充劑的偏好不斷增加，推動市場擴張。補充劑配方的技術進步，例如開發針對性和個人化的補充劑，將進一步推動市場成長。此外，透過線上平台和零售管道提供PMS、月經保健補充劑日益擴大消費者的獲取和便利。

市場限制因素：

儘管成長前景廣闊，PMS、月經保健品市場仍面臨監管障礙、產品功效和安全挑戰。監管標準因地區而異，這可能會對市場進入和產品審批帶來障礙。此外，缺乏支持某些補充劑有效性的標準化臨床證據可能會影響消費者信心和市場成長。高產品成本和有限的償付選項也對廣泛採用構成了挑戰，特別是在價格敏感的市場。

市場機會：

由於不斷變化的消費者偏好、人口趨勢和補充劑配方的創新，PMS、月經保健補充劑市場呈現出巨大的成長機會。人們對個人化健康和保健解決方案的日益關注，為開發滿足特定PMS、月經健康需求的客製化補充劑創造了機會。電子商務平台和保健食品商店等通路的擴大擴大了市場覆蓋範圍和可及性。策略合作夥伴關係、研發投資以及創新補充劑配方的推出對於利用新機會和維持市場成長非常重要。

本報告解決的關鍵問題

  • 推動PMS、月經保健品市場全球成長的關鍵因素是什麼？
  • 市面上流行哪些類型的補充品和配方？
  • 補充劑技術的進步如何改變PMS、月經保健品市場的競爭格局？
  • 誰是對PMS、月經健康補充劑市場做出貢獻的主要公司？
  • 全球PMS、月經保健品市場的新趨勢和未來前景如何？

目錄

第1章 執行摘要

第2章 市場概述

  • 市場範圍與定義
  • 市場動態
    • 促進因素
    • 抑制因素
    • 機會
    • 課題
    • 主要趨勢
  • 肉品替代品市場：價值鏈
    • 主要公司名單
    • 主要經銷商名單
  • 預測因子 - 相關性和影響
  • 新冠肺炎（COVID-19）影響評估
  • PESTLE分析
  • 波特五力分析

第3章 主要法規/標準

第4章 2019-2031年價格趨勢分析

  • 影響價格的主要因素
  • 以來源的價格

第5章 全球PMS、月經保健品市場展望：實績（2019-2023年）與預測（2024-2031年）

  • 市場規模分析與預測（十億美元）
    • 過去的市場規模分析，2019-2023年
    • 目前市場規模預測（2023-2031年）
  • 全球PMS、月經保健品市場展望：產品類型
    • 2019-2023年歷史市場規模（十億美元）分析，依產品類型
    • 2024-2031年目前市場規模（十億美元）預測，依產品類型
    • 市場吸引力分析：產品類型
  • 全球經前症候群/月經健康補充品市場展望：依消費者群體
    • 2019-2023年歷史市場規模（十億美元）分析，依消費者群體
    • 2024-2031年當前市場規模預測（十億美元），依消費者群體
    • 市場吸引力分析：消費者群體
  • 全球PMS、月經保健品市場展望：配方
    • 2019-2023年歷史市場規模（十億美元）分析：依配方
    • 對2024-2031年當前市場規模（十億美元）的預測：依配方
    • 市場吸引力分析：表述
  • 全球PMS、月經保健品市場展望：症狀
    • 2019-2023年過去的市場規模（十億美元）分析，依症狀
    • 2024-2031年當前市場規模（十億美元）預測，依症狀
    • 市場吸引力分析：症狀
  • 全球經前症候群/經期保健補充品市場展望：依銷售管道
    • 2019-2023年歷史市場規模（十億美元）分析：依類別
    • 2024-2031年當前市場規模（十億美元）預測：依類別
    • 市場吸引力分析：銷售管道

第6章 全球經前症候群/經期保健補充品市場展望：地區

  • 2019-2023年歷史市場規模分析（十億美元）：依地區
  • 2024-2031年當前市場規模預測（十億美元）：依地區
    • 北美
    • 歐洲
    • 東亞
    • 南亞/大洋洲
    • 拉丁美洲
    • 中東、非洲
  • 市場吸引力分析：地區

第7章 北美PMS、月經保健品市場展望：結果（2019-2023年）與預測（2024-2031年）

第8章 歐洲PMS、月經保健品市場展望：結果（2019-2023年）與預測（2024-2031年）

第9章 東亞 PMS、月經保健品市場展望：結果（2019-2023年）與預測（2024-2031年）

第10章 南亞/大洋洲 PMS、月經保健品市場展望：實績（2019-2023年）與預測（2024-2031年）

第11章 拉丁美洲PMS、月經保健品市場展望：實績（2019-2023年）與預測（2024-2031年）

第12章 中東和非洲PMS、月經保健品市場展望：實績（2019-2023年）和預測（2024-2031年）

第13章 競爭態勢

  • 2023年市佔率分析
  • 市場結構
    • 競爭強度圖：依市場
    • 競爭儀表板
    • 層次結構分析
    • 區域分佈分析
  • 公司簡介（詳細資料 - 概述、財務狀況、策略、近期發展）
    • Herbalife International of America, Inc.
    • Pharmavite LLC
    • Nature's Bounty
    • Amway
    • GNC Holdings Inc.
    • USANA Health Sciences, Inc.
    • MetP Pharma AG
    • RBk Neutraceuticals Pty. Ltd.
    • Archer Daniels Midland
    • Power Gummies
    • Looni
    • DM Pharma

第14章 附錄

  • 調查方法
  • 調查的先決條件
  • 首字母縮寫詞和縮寫詞
簡介目錄
Product Code: PMRREP34721

Persistence Market Research has recently released a comprehensive report on the PMS & Menstrual Health Supplements Market. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

  • PMS & Menstrual Health Supplements Market Size (2024E):US$24.2 Bn
  • Projected Market Value (2031F): US$35.6 Bn
  • Global Market Growth Rate (CAGR 2024 to 2031): 5.6%

PMS & Menstrual Health Supplements Market - Report Scope:

PMS and menstrual health supplements are designed to alleviate symptoms associated with premenstrual syndrome (PMS) and menstrual discomfort, including bloating, mood swings, and pain. These supplements often contain vitamins, minerals, herbal extracts, and other natural ingredients aimed at improving menstrual health and overall well-being. The market caters to women across various age groups and health conditions, offering a range of products including dietary supplements, herbal remedies, and functional foods. Market growth is driven by increasing awareness of menstrual health, rising demand for natural and organic supplements, and the growing emphasis on women's health and wellness.

Market Growth Drivers:

The global PMS & Menstrual Health Supplements market is propelled by several key factors, including heightened awareness and acceptance of PMS and menstrual health management solutions. The rising prevalence of PMS and menstrual disorders, coupled with increasing consumer preference for natural and organic supplements, drives market expansion. Technological advancements in supplement formulation, including the development of targeted and personalized supplements, further enhance market growth. Additionally, the growing availability of PMS and menstrual health supplements through online platforms and retail channels provides wider consumer access and convenience.

Market Restraints:

Despite promising growth prospects, the PMS & Menstrual Health Supplements market faces challenges related to regulatory hurdles, product efficacy, and safety concerns. Variations in regulatory standards across regions can create barriers for market entry and product approval. Additionally, the lack of standardized clinical evidence supporting the effectiveness of some supplements can impact consumer trust and market growth. High product costs and limited reimbursement options also pose challenges for widespread adoption, particularly in price-sensitive markets.

Market Opportunities:

The PMS & Menstrual Health Supplements market presents significant growth opportunities driven by evolving consumer preferences, demographic trends, and innovation in supplement formulations. The increasing focus on personalized health and wellness solutions creates opportunities for the development of tailored supplements that address specific PMS and menstrual health needs. Expanding distribution channels, including e-commerce platforms and health stores, enhance market reach and accessibility. Strategic partnerships, investment in research and development, and the introduction of innovative supplement formulations are crucial to capitalize on emerging opportunities and sustain market growth.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the PMS & Menstrual Health Supplements market globally?
  • Which supplement types and formulations are gaining traction in the market?
  • How are advancements in supplement technology reshaping the competitive landscape of the PMS & Menstrual Health Supplements market?
  • Who are the key players contributing to the PMS & Menstrual Health Supplements market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global PMS & Menstrual Health Supplements market?

Competitive Intelligence and Business Strategy:

Leading players in the global PMS & Menstrual Health Supplements market, including companies like Herbalife Nutrition Ltd., Amway Corporation, and Nature's Way, focus on product innovation, consumer education, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced supplement formulations, including personalized and targeted solutions for PMS and menstrual health. Collaborations with healthcare professionals, wellness influencers, and retail partners facilitate market access and promote consumer trust. Moreover, emphasis on quality assurance, clinical research, and evidence-based practices fosters market growth and enhances consumer satisfaction in the dynamic PMS & Menstrual Health Supplements landscape.

Key Companies Profiled:

  • Herbalife International of America, Inc.
  • Pharmavite LLC
  • Nature's Bounty
  • Amway; GNC Holdings Inc.
  • USANA Health Sciences, Inc.
  • GlaxoSmithKline Plc
  • MetP Pharma AG
  • RBK Nutraceuticals Pty Ltd.
  • Archer Daniels Midland
  • Power Gummies
  • Looni, DM Pharma

PMS & Menstrual Health Supplements Market Segmentation

By Product

  • Single Nutritional Supplements
  • Combined Nutritional Supplements

By Consumer Group Outlook

  • Premenstrual Syndrome (PMS)
  • Perimenopause

By Formulation

  • Capsules/Tablets
  • Powder
  • Softgels

By Symptom

  • Bloating and Fluid Retention
  • Mood Swings and Irritability
  • Breast Tenderness
  • Cramps and Pain
  • Fatigue
  • Anxiety

By Sales Channel

  • Online sales channel
  • Direct sales channel
  • Pharmacies/Drug stores
  • Other offline channels

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • The Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global PMS & Menstrual Health Supplements Market Snapshot, 2024-2031
  • 1.2. Market Opportunity Assessment, 2024-2031, US$ Bn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Industry Developments and Key Market Events
  • 1.6. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. Meat Substitutes Market: Value Chain
    • 2.3.1. List of key players
    • 2.3.2. List of key distributors
  • 2.4. Forecast Factors - Relevance and Impact
  • 2.5. Covid-19 Impact Assessment
  • 2.6. PESTLE Analysis
  • 2.7. Porter Five Force's Analysis

3. Key Regulations/ Standards

4. Price Trend Analysis, 2019-2031

  • 4.1. Key Factors Impacting Prices
  • 4.2. Prices by Source

5. Global PMS & Menstrual Health Supplements Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 5.1. Market Size (US$ Bn) Analysis and Forecast
    • 5.1.1. Historical Market Size Analysis, 2019-2023
    • 5.1.2. Current Market Size Forecast, 2023-2031
  • 5.2. Global PMS & Menstrual Health Supplements Market Outlook: Product Type
    • 5.2.1. Historical Market Size (US$ Bn) Analysis By Product Type, 2019-2023
    • 5.2.2. Current Market Size (US$ Bn) Forecast By Product Type, 2024-2031
      • 5.2.2.1. Single Nutritional Supplements
        • 5.2.2.1.1. Vitamins
        • 5.2.2.1.2. Minerals
        • 5.2.2.1.3. Herbal supplements
        • 5.2.2.1.4. Others
      • 5.2.2.2. Combined Nutritional Supplements
    • 5.2.3. Market Attractiveness Analysis: Product Type
  • 5.3. Global PMS & Menstrual Health Supplements Market Outlook: By Consumer Group
    • 5.3.1. Historical Market Size (US$ Bn) Analysis By Consumer Group, 2019-2023
    • 5.3.2. Current Market Size (US$ Bn) Forecast By Consumer Group, 2024-2031
        • 5.3.2.1.1. Premenstrual Syndrome (PMS)
        • 5.3.2.1.2. Perimenopause
    • 5.3.3. Market Attractiveness Analysis: Consumer Group
  • 5.4. Global PMS & Menstrual Health Supplements Market Outlook: Formulation
    • 5.4.1. Historical Market Size (US$ Bn) Analysis By Formulation, 2019-2023
    • 5.4.2. Current Market Size (US$ Bn) Forecast By Formulation, 2024-2031
        • 5.4.2.1.1. Capsules/Tablets
        • 5.4.2.1.2. Powder
        • 5.4.2.1.3. Softgels
        • 5.4.2.1.4. Others
    • 5.4.3. Market Attractiveness Analysis: Formulation
  • 5.5. Global PMS & Menstrual Health Supplements Market Outlook: Symptom
    • 5.5.1. Historical Market Size (US$ Bn) Analysis By Symptom, 2019-2023
    • 5.5.2. Current Market Size (US$ Bn) Forecast By Symptom, 2024-2031
      • 5.5.2.1. Bloating and Fluid Retention
      • 5.5.2.2. Mood Swings and Irritability
      • 5.5.2.3. Breast Tenderness
      • 5.5.2.4. Cramps and Pain
      • 5.5.2.5. Fatigue
      • 5.5.2.6. Anxiety
      • 5.5.2.7. Others
    • 5.5.3. Market Attractiveness Analysis: Symptom
  • 5.6. Global PMS & Menstrual Health Supplements Market Outlook: By Sales Channel
    • 5.6.1. Historical Market Size (US$ Bn) Analysis By Category, 2019-2023
    • 5.6.2. Current Market Size (US$ Bn) Forecast By Category, 2024-2031
      • 5.6.2.1. Online sales channel
      • 5.6.2.2. Direct sales channel
      • 5.6.2.3. Pharmacies/Drug stores
      • 5.6.2.4. Other offline channels
    • 5.6.3. Market Attractiveness Analysis: Sales Channel

6. Global PMS & Menstrual Health Supplements Market Outlook: Region

  • 6.1. Historical Market Size (US$ Bn) Analysis By Region, 2019-2023
  • 6.2. Current Market Size (US$ Bn) Forecast By Region, 2024-2031
    • 6.2.1. North America
    • 6.2.2. Europe
    • 6.2.3. East Asia
    • 6.2.4. South Asia and Oceania
    • 6.2.5. Latin America
    • 6.2.6. Middle East & Africa
  • 6.3. Market Attractiveness Analysis: Region

7. North America PMS & Menstrual Health Supplements Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 7.1. Historical Market Size (US$ Bn) Analysis By Market, 2019-2023
    • 7.1.1. By Country
    • 7.1.2. By Product Type
    • 7.1.3. By Consumer Group
    • 7.1.4. By Formulation
    • 7.1.5. By Symptom
    • 7.1.6. By Sales Channel
  • 7.2. Current Market Size (US$ Bn) Forecast By Country, 2024-2031
    • 7.2.1. U.S.
    • 7.2.2. Canada
  • 7.3. North America PMS & Menstrual Health Supplements Market Outlook: Product Type
    • 7.3.1. Historical Market Size (US$ Bn) Analysis By Product Type, 2019-2023
    • 7.3.2. Current Market Size (US$ Bn) Forecast By Product Type, 2024-2031
      • 7.3.2.1. Single Nutritional Supplements
        • 7.3.2.1.1. Vitamins
        • 7.3.2.1.2. Minerals
        • 7.3.2.1.3. Herbal supplements
        • 7.3.2.1.4. Others
      • 7.3.2.2. Combined Nutritional Supplements
    • 7.3.3. Market Attractiveness Analysis: Product Type
  • 7.4. North America PMS & Menstrual Health Supplements Market Outlook: By Consumer Group
    • 7.4.1. Historical Market Size (US$ Bn) Analysis By Consumer Group, 2019-2023
    • 7.4.2. Current Market Size (US$ Bn) Forecast By Consumer Group, 2024-2031
      • 7.4.2.1. Premenstrual Syndrome (PMS)
      • 7.4.2.2. Perimenopause
    • 7.4.3. Market Attractiveness Analysis: Consumer Group
  • 7.5. North America PMS & Menstrual Health Supplements Market Outlook: Formulation
    • 7.5.1. Historical Market Size (US$ Bn) Analysis By Formulation, 2019-2023
    • 7.5.2. Current Market Size (US$ Bn) Forecast By Formulation, 2024-2031
      • 7.5.2.1. Capsules/Tablets
      • 7.5.2.2. Powder
      • 7.5.2.3. Softgels
      • 7.5.2.4. Others
    • 7.5.3. Market Attractiveness Analysis: Formulation
  • 7.6. North America PMS & Menstrual Health Supplements Market Outlook: Symptom
    • 7.6.1. Historical Market Size (US$ Bn) Analysis By Symptom, 2019-2023
    • 7.6.2. Current Market Size (US$ Bn) Forecast By Symptom, 2024-2031
      • 7.6.2.1. Bloating and Fluid Retention
      • 7.6.2.2. Mood Swings and Irritability
      • 7.6.2.3. Breast Tenderness
      • 7.6.2.4. Cramps and Pain
      • 7.6.2.5. Fatigue
      • 7.6.2.6. Anxiety
      • 7.6.2.7. Others
    • 7.6.3. Market Attractiveness Analysis: Symptom
  • 7.7. North America PMS & Menstrual Health Supplements Market Outlook: By Sales Channel
    • 7.7.1. Historical Market Size (US$ Bn) Analysis By Category, 2019-2023
    • 7.7.2. Current Market Size (US$ Bn) Forecast By Category, 2024-2031
      • 7.7.2.1. Online sales channel
      • 7.7.2.2. Direct sales channel
      • 7.7.2.3. Pharmacies/Drug stores
      • 7.7.2.4. Other offline channels
    • 7.7.3. Market Attractiveness Analysis: Sales Channel
  • 7.8. Market Attractiveness Analysis

8. Europe PMS & Menstrual Health Supplements Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 8.1. Historical Market Size (US$ Bn) Analysis By Market, 2019-2023
    • 8.1.1. By Country
    • 8.1.2. By Product Type
    • 8.1.3. By Consumer Group
    • 8.1.4. By Formulation
    • 8.1.5. By Symptom
    • 8.1.6. By Sales Channel
  • 8.2. Current Market Size (US$ Bn) Forecast By Country, 2024-2031
    • 8.2.1. Germany
    • 8.2.2. France
    • 8.2.3. U.K.
    • 8.2.4. Italy
    • 8.2.5. Spain
    • 8.2.6. Russia
  • 8.3. Europe PMS & Menstrual Health Supplements Market Outlook: Product Type
    • 8.3.1. Historical Market Size (US$ Bn) Analysis By Product Type, 2019-2023
    • 8.3.2. Current Market Size (US$ Bn) Forecast By Product Type, 2024-2031
      • 8.3.2.1. Single Nutritional Supplements
        • 8.3.2.1.1. Vitamins
        • 8.3.2.1.2. Minerals
        • 8.3.2.1.3. Herbal supplements
        • 8.3.2.1.4. Others
      • 8.3.2.2. Combined Nutritional Supplements
    • 8.3.3. Market Attractiveness Analysis: Product Type
  • 8.4. Europe PMS & Menstrual Health Supplements Market Outlook: By Consumer Group
    • 8.4.1. Historical Market Size (US$ Bn) Analysis By Consumer Group, 2019-2023
    • 8.4.2. Current Market Size (US$ Bn) Forecast By Consumer Group, 2024-2031
      • 8.4.2.1. Premenstrual Syndrome (PMS)
      • 8.4.2.2. Perimenopause
    • 8.4.3. Market Attractiveness Analysis: Consumer Group
  • 8.5. Europe PMS & Menstrual Health Supplements Market Outlook: Formulation
    • 8.5.1. Historical Market Size (US$ Bn) Analysis By Formulation, 2019-2023
    • 8.5.2. Current Market Size (US$ Bn) Forecast By Formulation, 2024-2031
      • 8.5.2.1. Capsules/Tablets
      • 8.5.2.2. Powder
      • 8.5.2.3. Softgels
      • 8.5.2.4. Others
    • 8.5.3. Market Attractiveness Analysis: Formulation
  • 8.6. Europe PMS & Menstrual Health Supplements Market Outlook: Symptom
    • 8.6.1. Historical Market Size (US$ Bn) Analysis By Symptom, 2019-2023
    • 8.6.2. Current Market Size (US$ Bn) Forecast By Symptom, 2024-2031
      • 8.6.2.1. Bloating and Fluid Retention
      • 8.6.2.2. Mood Swings and Irritability
      • 8.6.2.3. Breast Tenderness
      • 8.6.2.4. Cramps and Pain
      • 8.6.2.5. Fatigue
      • 8.6.2.6. Anxiety
      • 8.6.2.7. Others
    • 8.6.3. Market Attractiveness Analysis: Symptom
  • 8.7. Europe PMS & Menstrual Health Supplements Market Outlook: By Sales Channel
    • 8.7.1. Historical Market Size (US$ Bn) Analysis By Category, 2019-2023
    • 8.7.2. Current Market Size (US$ Bn) Forecast By Category, 2024-2031
      • 8.7.2.1. Online sales channel
      • 8.7.2.2. Direct sales channel
      • 8.7.2.3. Pharmacies/Drug stores
      • 8.7.2.4. Other offline channels
    • 8.7.3. Market Attractiveness Analysis: Sales Channel
  • 8.8. Market Attractiveness Analysis

9. East Asia PMS & Menstrual Health Supplements Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 9.1. Historical Market Size (US$ Bn) Analysis By Market, 2019-2023
    • 9.1.1. By Country
    • 9.1.2. By Product Type
    • 9.1.3. By Consumer Group
    • 9.1.4. By Formulation
    • 9.1.5. By Symptom
    • 9.1.6. By Sales Channel
  • 9.2. Current Market Size (US$ Bn) Forecast By Country, 2024-2031
    • 9.2.1. China
    • 9.2.2. Japan
    • 9.2.3. South Korea
  • 9.3. East Asia PMS & Menstrual Health Supplements Market Outlook: Product Type
    • 9.3.1. Historical Market Size (US$ Bn) Analysis By Product Type, 2019-2023
    • 9.3.2. Current Market Size (US$ Bn) Forecast By Product Type, 2024-2031
      • 9.3.2.1. Single Nutritional Supplements
        • 9.3.2.1.1. Vitamins
        • 9.3.2.1.2. Minerals
        • 9.3.2.1.3. Herbal supplements
        • 9.3.2.1.4. Others
      • 9.3.2.2. Combined Nutritional Supplements
    • 9.3.3. Market Attractiveness Analysis: Product Type
  • 9.4. East Asia PMS & Menstrual Health Supplements Market Outlook: By Consumer Group
    • 9.4.1. Historical Market Size (US$ Bn) Analysis By Consumer Group, 2019-2023
    • 9.4.2. Current Market Size (US$ Bn) Forecast By Consumer Group, 2024-2031
      • 9.4.2.1. Premenstrual Syndrome (PMS)
      • 9.4.2.2. Perimenopause
    • 9.4.3. Market Attractiveness Analysis: Consumer Group
  • 9.5. East Asia PMS & Menstrual Health Supplements Market Outlook: Formulation
    • 9.5.1. Historical Market Size (US$ Bn) Analysis By Formulation, 2019-2023
    • 9.5.2. Current Market Size (US$ Bn) Forecast By Formulation, 2024-2031
      • 9.5.2.1. Capsules/Tablets
      • 9.5.2.2. Powder
      • 9.5.2.3. Softgels
      • 9.5.2.4. Others
    • 9.5.3. Market Attractiveness Analysis: Formulation
  • 9.6. East Asia PMS & Menstrual Health Supplements Market Outlook: Symptom
    • 9.6.1. Historical Market Size (US$ Bn) Analysis By Symptom, 2019-2023
    • 9.6.2. Current Market Size (US$ Bn) Forecast By Symptom, 2024-2031
      • 9.6.2.1. Bloating and Fluid Retention
      • 9.6.2.2. Mood Swings and Irritability
      • 9.6.2.3. Breast Tenderness
      • 9.6.2.4. Cramps and Pain
      • 9.6.2.5. Fatigue
      • 9.6.2.6. Anxiety
      • 9.6.2.7. Others
    • 9.6.3. Market Attractiveness Analysis: Symptom
  • 9.7. East Asia PMS & Menstrual Health Supplements Market Outlook: By Sales Channel
    • 9.7.1. Historical Market Size (US$ Bn) Analysis By Category, 2019-2023
    • 9.7.2. Current Market Size (US$ Bn) Forecast By Category, 2024-2031
      • 9.7.2.1. Online sales channel
      • 9.7.2.2. Direct sales channel
      • 9.7.2.3. Pharmacies/Drug stores
      • 9.7.2.4. Other offline channels
    • 9.7.3. Market Attractiveness Analysis: Sales Channel

10. South Asia & Oceania PMS & Menstrual Health Supplements Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 10.1. Historical Market Size (US$ Bn) Analysis By Market, 2019-2023
    • 10.1.1. By Country
    • 10.1.2. By Product Type
    • 10.1.3. By Consumer Group
    • 10.1.4. By Formulation
    • 10.1.5. By Symptom
    • 10.1.6. By Sales Channel
  • 10.2. Current Market Size (US$ Bn) Forecast By Country, 2024-2031
    • 10.2.1. India
    • 10.2.2. Southeast Asia
    • 10.2.3. ANZ
    • 10.2.4. Rest of South Asia & Oceania
  • 10.3. South Asia & Oceania PMS & Menstrual Health Supplements Market Outlook: Product Type
    • 10.3.1. Historical Market Size (US$ Bn) Analysis By Product Type, 2019-2023
    • 10.3.2. Current Market Size (US$ Bn) Forecast By Product Type, 2024-2031
      • 10.3.2.1. Single Nutritional Supplements
        • 10.3.2.1.1. Vitamins
        • 10.3.2.1.2. Minerals
        • 10.3.2.1.3. Herbal supplements
        • 10.3.2.1.4. Others
      • 10.3.2.2. Combined Nutritional Supplements
    • 10.3.3. Market Attractiveness Analysis: Product Type
  • 10.4. South Asia & Oceania PMS & Menstrual Health Supplements Market Outlook: By Consumer Group
    • 10.4.1. Historical Market Size (US$ Bn) Analysis By Consumer Group, 2019-2023
    • 10.4.2. Current Market Size (US$ Bn) Forecast By Consumer Group, 2024-2031
      • 10.4.2.1. Premenstrual Syndrome (PMS)
      • 10.4.2.2. Perimenopause
    • 10.4.3. Market Attractiveness Analysis: Consumer Group
  • 10.5. South Asia & Oceania PMS & Menstrual Health Supplements Market Outlook: Formulation
    • 10.5.1. Historical Market Size (US$ Bn) Analysis By Formulation, 2019-2023
    • 10.5.2. Current Market Size (US$ Bn) Forecast By Formulation, 2024-2031
      • 10.5.2.1. Capsules/Tablets
      • 10.5.2.2. Powder
      • 10.5.2.3. Softgels
      • 10.5.2.4. Others
    • 10.5.3. Market Attractiveness Analysis: Formulation
  • 10.6. South Asia & Oceania PMS & Menstrual Health Supplements Market Outlook: Symptom
    • 10.6.1. Historical Market Size (US$ Bn) Analysis By Symptom, 2019-2023
    • 10.6.2. Current Market Size (US$ Bn) Forecast By Symptom, 2024-2031
      • 10.6.2.1. Bloating and Fluid Retention
      • 10.6.2.2. Mood Swings and Irritability
      • 10.6.2.3. Breast Tenderness
      • 10.6.2.4. Cramps and Pain
      • 10.6.2.5. Fatigue
      • 10.6.2.6. Anxiety
      • 10.6.2.7. Others
    • 10.6.3. Market Attractiveness Analysis: Symptom
  • 10.7. Europe PMS & Menstrual Health Supplements Market Outlook: By Sales Channel
    • 10.7.1. Historical Market Size (US$ Bn) Analysis By Category, 2019-2023
    • 10.7.2. Current Market Size (US$ Bn) Forecast By Category, 2024-2031
      • 10.7.2.1. Online sales channel
      • 10.7.2.2. Direct sales channel
      • 10.7.2.3. Pharmacies/Drug stores
      • 10.7.2.4. Other offline channels
    • 10.7.3. Market Attractiveness Analysis: Sales Channel
  • 10.8. Market Attractiveness Analysis

11. Latin America PMS & Menstrual Health Supplements Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 11.1. Historical Market Size (US$ Bn) Analysis By Market, 2019-2023
    • 11.1.1. By Country
    • 11.1.2. By Product Type
    • 11.1.3. By Consumer Group
    • 11.1.4. By Formulation
    • 11.1.5. By Symptom
    • 11.1.6. By Sales Channel
  • 11.2. Current Market Size (US$ Bn) Forecast By Country, 2024-2031
    • 11.2.1. Brazil
    • 11.2.2. Mexico
  • 11.3. Latin America PMS & Menstrual Health Supplements Market Outlook: Product Type
    • 11.3.1. Historical Market Size (US$ Bn) Analysis By Product Type, 2019-2023
    • 11.3.2. Current Market Size (US$ Bn) Forecast By Product Type, 2024-2031
      • 11.3.2.1. Single Nutritional Supplements
        • 11.3.2.1.1. Vitamins
        • 11.3.2.1.2. Minerals
        • 11.3.2.1.3. Herbal supplements
        • 11.3.2.1.4. Others
      • 11.3.2.2. Combined Nutritional Supplements
    • 11.3.3. Market Attractiveness Analysis: Product Type
  • 11.4. Latin America PMS & Menstrual Health Supplements Market Outlook: By Consumer Group
    • 11.4.1. Historical Market Size (US$ Bn) Analysis By Consumer Group, 2019-2023
    • 11.4.2. Current Market Size (US$ Bn) Forecast By Consumer Group, 2024-2031
      • 11.4.2.1. Premenstrual Syndrome (PMS)
      • 11.4.2.2. Perimenopause
    • 11.4.3. Market Attractiveness Analysis: Consumer Group
  • 11.5. Latin America PMS & Menstrual Health Supplements Market Outlook: Formulation
    • 11.5.1. Historical Market Size (US$ Bn) Analysis By Formulation, 2019-2023
    • 11.5.2. Current Market Size (US$ Bn) Forecast By Formulation, 2024-2031
      • 11.5.2.1. Capsules/Tablets
      • 11.5.2.2. Powder
      • 11.5.2.3. Softgels
      • 11.5.2.4. Others
    • 11.5.3. Market Attractiveness Analysis: Formulation
  • 11.6. Latin America PMS & Menstrual Health Supplements Market Outlook: Symptom
    • 11.6.1. Historical Market Size (US$ Bn) Analysis By Symptom, 2019-2023
    • 11.6.2. Current Market Size (US$ Bn) Forecast By Symptom, 2024-2031
      • 11.6.2.1. Bloating and Fluid Retention
      • 11.6.2.2. Mood Swings and Irritability
      • 11.6.2.3. Breast Tenderness
      • 11.6.2.4. Cramps and Pain
      • 11.6.2.5. Fatigue
      • 11.6.2.6. Anxiety
      • 11.6.2.7. Others
    • 11.6.3. Market Attractiveness Analysis: Symptom
  • 11.7. Latin America PMS & Menstrual Health Supplements Market Outlook: By Sales Channel
    • 11.7.1. Historical Market Size (US$ Bn) Analysis By Category, 2019-2023
    • 11.7.2. Current Market Size (US$ Bn) Forecast By Category, 2024-2031
      • 11.7.2.1. Online sales channel
      • 11.7.2.2. Direct sales channel
      • 11.7.2.3. Pharmacies/Drug stores
      • 11.7.2.4. Other offline channels
    • 11.7.3. Market Attractiveness Analysis: Sales Channel
  • 11.8. Market Attractiveness Analysis

12. Middle East & Africa PMS & Menstrual Health Supplements Market Outlook: Historical (2019-2023) and Forecast (2024-2031)

  • 12.1. Historical Market Size (US$ Bn) Analysis By Market, 2019-2023
    • 12.1.1. By Country
    • 12.1.2. By Product Type
    • 12.1.3. By Consumer Group
    • 12.1.4. By Formulation
    • 12.1.5. By Symptom
    • 12.1.6. By Sales Channel
  • 12.2. Current Market Size (US$ Bn) Forecast By Country, 2024-2031
    • 12.2.1. GCC
    • 12.2.2. South Africa
    • 12.2.3. Northern Africa
  • 12.3. Middle East & Africa PMS & Menstrual Health Supplements Market Outlook: Product Type
    • 12.3.1. Historical Market Size (US$ Bn) Analysis By Product Type, 2019-2023
    • 12.3.2. Current Market Size (US$ Bn) Forecast By Product Type, 2024-2031
      • 12.3.2.1. Single Nutritional Supplements
        • 12.3.2.1.1. Vitamins
        • 12.3.2.1.2. Minerals
        • 12.3.2.1.3. Herbal supplements
        • 12.3.2.1.4. Others
      • 12.3.2.2. Combined Nutritional Supplements
    • 12.3.3. Market Attractiveness Analysis: Product Type
  • 12.4. Middle East & Africa PMS & Menstrual Health Supplements Market Outlook: By Consumer Group
    • 12.4.1. Historical Market Size (US$ Bn) Analysis By Consumer Group, 2019-2023
    • 12.4.2. Current Market Size (US$ Bn) Forecast By Consumer Group, 2024-2031
      • 12.4.2.1. Premenstrual Syndrome (PMS)
      • 12.4.2.2. Perimenopause
    • 12.4.3. Market Attractiveness Analysis: Consumer Group
  • 12.5. Middle East & Africa PMS & Menstrual Health Supplements Market Outlook: Formulation
    • 12.5.1. Historical Market Size (US$ Bn) Analysis By Formulation, 2019-2023
    • 12.5.2. Current Market Size (US$ Bn) Forecast By Formulation, 2024-2031
      • 12.5.2.1. Capsules/Tablets
      • 12.5.2.2. Powder
      • 12.5.2.3. Softgels
      • 12.5.2.4. Others
    • 12.5.3. Market Attractiveness Analysis: Formulation
  • 12.6. Middle East & Africa PMS & Menstrual Health Supplements Market Outlook: Symptom
    • 12.6.1. Historical Market Size (US$ Bn) Analysis By Symptom, 2019-2023
    • 12.6.2. Current Market Size (US$ Bn) Forecast By Symptom, 2024-2031
      • 12.6.2.1. Bloating and Fluid Retention
      • 12.6.2.2. Mood Swings and Irritability
      • 12.6.2.3. Breast Tenderness
      • 12.6.2.4. Cramps and Pain
      • 12.6.2.5. Fatigue
      • 12.6.2.6. Anxiety
      • 12.6.2.7. Others
    • 12.6.3. Market Attractiveness Analysis: Symptom
  • 12.7. Middle East & Africa PMS & Menstrual Health Supplements Market Outlook: By Sales Channel
    • 12.7.1. Historical Market Size (US$ Bn) Analysis By Category, 2019-2023
    • 12.7.2. Current Market Size (US$ Bn) Forecast By Category, 2024-2031
      • 12.7.2.1. Online sales channel
      • 12.7.2.2. Direct sales channel
      • 12.7.2.3. Pharmacies/Drug stores
      • 12.7.2.4. Other offline channels
    • 12.7.3. Market Attractiveness Analysis: Sales Channel
  • 12.8. Market Attractiveness Analysis

13. Competition Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. Market Structure
    • 13.2.1. Competition Intensity Mapping By Market
    • 13.2.2. Competition Dashboard
    • 13.2.3. Tier Structure Analysis
    • 13.2.4. Regional Presence Analysis
  • 13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 13.3.1. Herbalife International of America, Inc.
      • 13.3.1.1. Overview
      • 13.3.1.2. Segments and Products
      • 13.3.1.3. Key Financials
      • 13.3.1.4. Market Developments
      • 13.3.1.5. Market Strategy
    • 13.3.2. Pharmavite LLC
    • 13.3.3. Nature's Bounty
    • 13.3.4. Amway
    • 13.3.5. GNC Holdings Inc.
    • 13.3.6. USANA Health Sciences, Inc.
    • 13.3.7. MetP Pharma AG
    • 13.3.8. RBk Neutraceuticals Pty. Ltd.
    • 13.3.9. Archer Daniels Midland
    • 13.3.10. Power Gummies
    • 13.3.11. Looni
    • 13.3.12. DM Pharma

14. Appendix

  • 14.1. Research Methodology
  • 14.2. Research Assumptions
  • 14.3. Acronyms and Abbreviations